Exobiosphere
Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Trust68Data Trust: 68/100. Above median. Measured by StartupHub.ai. Median 61.Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.
About
Exobiosphere is a Luxembourg-based biotechnology company that is pioneering high-throughput drug discovery in microgravity. They are building the Orbital High-Throughput Screener (OHTS), an autonomous, standardized lab automation platform designed for space, enabling pharmaceutical and biotech partners to run automated experiments in orbit at scale. The company aims to accelerate drug discovery and unlock therapies that are difficult or impossible to develop on Earth by leveraging the unique conditions of microgravity.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Biotech
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
A vertically-integrated procurement platform for the life sciences industry.
Shares Biotechnology, Biotech
Key facts
- Website
- exobiosphere.com
- Headquarters
- Esch-sur-Alzette, Luxembourg
- Founded
- 2024
- Employees
- 27
- Total funding
- $3M (Grant)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Aug 2026 | Grant | $1M | |
| 4 Apr 2025 | Seed | $2M | Expansion, Expon Capital |
Tech stack
Detected on exobiosphere.com, last scanned 6 Nov 2026. Run your own scan
- CMS / Builders
- Squarespace
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Exobiosphere trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Exobiosphere is 68 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Exobiosphere raised?
Exobiosphere has raised a total of $3M in funding. The most recent round on record is Grant.
How many employees does Exobiosphere have?
Exobiosphere has approximately 27 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Exobiosphere:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
